Combating an Epidemic: Legislation to Help Patients with Substance Use Disorders

Admiral Brett P. Giroir
Assistant Secretary for Health and Senior Adviser to the Secretary on Opioid Policy, U.S. Department of Health and Human Services

• Joint Statement of ADM Brett P. Giroir, M.D. and Kimberly Brandt

Kimberly Brandt
Principal Deputy Administrator for Policy & Operations, Centers for Medicare & Medicaid Services

Thomas W. Prevoznik
Deputy Assistant Administrator, Diversion Control Division, Drug Enforcement Administration

• Witness Statement

Michael P. Botticelli
Executive Director, Grayken Center for Addiction, Boston Medical Center

• Witness Statement

Dr. Smita Das M.D., Ph.D., MPH
Addiction Psychiatrist, Dual Diagnosis Clinic, Stanford University School of Medicine, Clinical Assistant Professor, Psychiatry and Behavioral Sciences

• Witness Statement

Patty McCarthy
Chief Executive Officer, Faces and Voices of Recovery

• Witness Statement

Robert I.L. Morrison
Executive Director/Director of Legislative Affairs, National Association of State Alcohol and Drug Abuse Directors

• Witness Statement

Margaret B. Rizzo
Executive Director, JSAS HealthCare, Inc.

• Witness Statement

Dr. Shawn A. Ryan
Chair, Legislative Advocacy Committee, American Society of Addiction Medicine

• Witness Statement